Yingkai Cheng

Trastuzumab Deruxtecan in <i>HER2</i> -Mutant Non–Small-Cell Lung Cancer

Bob T. Li, Egbert F. Smit, Yasushi Goto et al. · New England Journal of Medicine · 2021 · 980 citations · Full text

Medicine, Oncology, Pharmacology +16

Trastuzumab Deruxtecan in Patients With <i>HER2</i>-Mutant Metastatic Non–Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial

Kōichi Goto, Yasushi Goto, Toshio Kubo et al. · Journal of Clinical Oncology · 2023 · 299 citations · Full text

Medicine, Oncology, Pharmacology +17

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

Egbert F. Smit, Enriqueta Felip, Dipesh Uprety et al. · The Lancet Oncology · 2024 · 156 citations · Full text

Medicine, Oncology, Pharmacology +16

Prevalence and correlates of opiate overdose among young injection drug users in a large U.S. city

Susan G. Sherman, Yingkai Cheng, Alex H. Kral · Drug and Alcohol Dependence · 2006 · 85 citations · Full text

Medicine, Pharmacology, Psychiatry +15

Risk factors associated with injection initiation among drug users in Northern Thailand

Yingkai Cheng, Susan G. Sherman, Namtip Srirat et al. · Harm Reduction Journal · 2006 · 46 citations · Full text

Public Health, Health Behavior, Substance Use Disorders +12